secwatch.observer — SEC 8-K summary
======================================

Issuer:     vTv Therapeutics Inc. (VTVT)
CIK:        0001641489
Form:       8-K
Filed at:   2026-06-29T20:14:37+00:00
Accession:  0001641489-26-000024
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

vTv Therapeutics annual meeting: three directors face over 1.8M withheld votes
------------------------------------------------------------------------------

- Stockholders elected 7 directors; Srinivas Akkaraju, Raymond Cheong, Daniel Spiegelman each received >1.8M withheld votes.
- Fahed Al Marzooqi and Richard S. Nelson received strong support (2.4M for, 264K withheld).
- Ratification of Ernst & Young as auditor passed with 99.9% for (2,964,869 for, 1,952 against).
- Advisory say-on-pay vote: 686,535 for, 5,291 against, and 1,967,329 abstentions (310,535 broker non-votes).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/0001641489-26-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1641489/000164148926000024/vtvt-20260626.htm
  HTML page:      https://secwatch.observer/filing/0001641489-26-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer